What is the address of J.J. MED?

The registered office of J.J. MED is located at Rue des Frères Gilbert 6, 7800 Ath.

Is J.J. MED still active?

Yes. According to the CBE (29 September 2026) J.J. MED is active, legal situation “Normale toestand”, started on 27 January 2010.

Is J.J. MED registered on Peppol?

Yes, J.J. MED is registered on the Peppol network with ID 0208:0822636313.

What is the enterprise number of J.J. MED?

The enterprise number of J.J. MED is BE0822636313.

When was J.J. MED founded?

J.J. MED was founded on 27 January 2010.

Who are the directors of J.J. MED?

According to the 2025 annual accounts, the directors of J.J. MED are: Roopa Jagannath.

Is J.J. MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 January 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did J.J. MED make in 2025?

J.J. MED posted a profit after taxes of € 47,750 in financial year 2025.

What is the revenue of J.J. MED?

As a small company, J.J. MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 69,695.

J.J. MED (Private Limited) - Ath - BE0822636313

Dossier J.J. MED, printed on 29 September 2026 from databakkes.be/en/0822636313/j-j-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

J.J. MED from Ath, company number BE0822636313, closed financial year 2025 with a result of € 47,750 after tax. For that financial year J.J. MED recorded a gross margin of € 69,695 and equity of € 226,554. Compared with financial year 2024, the result moved from € 46,310 to € 47,750. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What it is worth Healthy

€ 226,554

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 47,750

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 105,768

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 65,530 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,179

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 76

▼ 97% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,467

▲ 23% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 62,499 Gross margin 2022: € 62,499 First fiscal year in the series	€ 63,393 Gross margin 2023: € 63,393 ▲ 1% vs 2022 (€ 62,499) Favourable step	€ 65,000 Gross margin 2024: € 65,000 ▲ 3% vs 2023 (€ 63,393) Favourable step	€ 69,695 Gross margin 2025: € 69,695 ▲ 7% vs 2024 (€ 65,000) Favourable step	▲ 7%
Profit after taxes	€ 41,099 Profit after taxes 2022: € 41,099 First fiscal year in the series	€ 42,149 Profit after taxes 2023: € 42,149 ▲ 3% vs 2022 (€ 41,099) Favourable step	€ 46,310 Profit after taxes 2024: € 46,310 ▲ 10% vs 2023 (€ 42,149) Favourable step	€ 47,750 Profit after taxes 2025: € 47,750 ▲ 3% vs 2024 (€ 46,310) Favourable step	▲ 3%
Equity	€ 220,375 Equity 2022: € 220,375 First fiscal year in the series	€ 202,024 Equity 2023: € 202,024 ▼ 8% vs 2022 (€ 220,375) Unfavourable step	€ 244,334 Equity 2024: € 244,334 ▲ 21% vs 2023 (€ 202,024) Favourable step	€ 226,554 Equity 2025: € 226,554 ▼ 7% vs 2024 (€ 244,334) Unfavourable step	▼ 7%
Total debts	€ 52,467 Total debts 2022: € 52,467 First fiscal year in the series	€ 82,899 Total debts 2023: € 82,899 ▲ 58% vs 2022 (€ 52,467) Unfavourable step	€ 17,363 Total debts 2024: € 17,363 ▼ 79% vs 2023 (€ 82,899) Favourable step	€ 44,841 Total debts 2025: € 44,841 ▲ 158% vs 2024 (€ 17,363) Unfavourable step	▲ 158%
Cash	€ 261,428 Cash 2022: € 261,428 First fiscal year in the series	€ 273,316 Cash 2023: € 273,316 ▲ 5% vs 2022 (€ 261,428) Favourable step	€ 112,393 Cash 2024: € 112,393 ▼ 59% vs 2023 (€ 273,316) Unfavourable step	€ 105,768 Cash 2025: € 105,768 ▼ 6% vs 2024 (€ 112,393) Unfavourable step	▼ 6%
Retained profit	€ 207,975 Retained profit 2022: € 207,975 First fiscal year in the series	€ 189,624 Retained profit 2023: € 189,624 ▼ 9% vs 2022 (€ 207,975) Unfavourable step	€ 231,934 Retained profit 2024: € 231,934 ▲ 22% vs 2023 (€ 189,624) Favourable step	€ 214,154 Retained profit 2025: € 214,154 ▼ 8% vs 2024 (€ 231,934) Unfavourable step	▼ 8%
Dividend	€ 69,000 Dividend 2022: € 69,000 First fiscal year in the series	€ 60,500 Dividend 2023: € 60,500 ▼ 12% vs 2022 (€ 69,000) Unchanged	€ 4,000 Dividend 2024: € 4,000 ▼ 93% vs 2023 (€ 60,500) Unchanged	€ 65,530 Dividend 2025: € 65,530 ▲ € 61,530 vs 2024 (€ 4,000) Unchanged	▲ € 61,530
Balance sheet total	€ 272,843 Balance sheet total 2022: € 272,843 First fiscal year in the series	€ 284,923 Balance sheet total 2023: € 284,923 ▲ 4% vs 2022 (€ 272,843) Unchanged	€ 261,697 Balance sheet total 2024: € 261,697 ▼ 8% vs 2023 (€ 284,923) Unchanged	€ 271,395 Balance sheet total 2025: € 271,395 ▲ 4% vs 2024 (€ 261,697) Unchanged	▲ 4%

Key figures of J.J. MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to J.J. MED?

What happened at J.J. MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 17, 2026 New annual accounts for financial year 2025: profit of € 47,750 (▲ 3% vs 2024). Source: NBB ↗
Jan 27, 2010 New establishment in Ath. KBO
Jan 27, 2010 Start of the company according to the CBE. KBO

In short

From € 41,099 profit in 2022 to € 47,750 profit in 2025.

Paid € 76,866 in corporate taxes since 2022.

Best year ever: 2025, with € 47,750 profit.

Paid out € 199,030 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at J.J. MED? We notify you, reason included.

Follow J.J. MED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Roopa Jagannath

J.J. MED

Behind J.J. MED is Roopa Jagannath.

See the full network in the app

Directors

According to the 2025 annual accounts

Roopa Jagannath

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Frères Gilbert 6

7800 Ath

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0822.636.313
VAT number: BE 0822.636.313
Registered office: Rue des Frères Gilbert 6, 7800 Ath
Names & denominations: J.J. MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 January 2010
Peppol: Active · Active since 24 Jun 2026

View on CBE Public ↗ Annual accounts (NBB) ↗